| Title |
Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty
|
|---|---|
| Published in |
Clinical Orthopaedics & Related Research, January 2013
|
| DOI | 10.1007/s11999-012-2488-z |
| Pubmed ID | |
| Authors |
Blake P. Gillette, Lori J. DeSimone, Robert T. Trousdale, Mark W. Pagnano, Rafael J. Sierra |
| Abstract |
The use of antifibrinolytic medications in hip and knee arthroplasty reduces intraoperative blood loss and decreases transfusion rates postoperatively. Tranexamic acid (TXA) specifically has not been associated with increased thromboembolic (TE) complications, but concerns remain about the risk of symptomatic TE events, particularly when less aggressive chemical prophylaxis methods such as aspirin alone are chosen. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 33% |
| Saudi Arabia | 1 | 17% |
| United Kingdom | 1 | 17% |
| Spain | 1 | 17% |
| Unknown | 1 | 17% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
| Science communicators (journalists, bloggers, editors) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| Brazil | 2 | 1% |
| United States | 2 | 1% |
| Iceland | 1 | <1% |
| Switzerland | 1 | <1% |
| Unknown | 132 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 35 | 25% |
| Researcher | 21 | 15% |
| Student > Postgraduate | 15 | 11% |
| Student > Master | 14 | 10% |
| Student > Bachelor | 12 | 9% |
| Other | 29 | 21% |
| Unknown | 14 | 10% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 98 | 70% |
| Nursing and Health Professions | 8 | 6% |
| Agricultural and Biological Sciences | 6 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | <1% |
| Arts and Humanities | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 26 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2012.
All research outputs
#7,302,411
of 25,374,647 outputs
Outputs from Clinical Orthopaedics & Related Research
#2,012
of 7,298 outputs
Outputs of similar age
#72,340
of 289,004 outputs
Outputs of similar age from Clinical Orthopaedics & Related Research
#31
of 158 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 7,298 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,004 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 158 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.